Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevention and management of drug resistance for antihepatitis B treatment.

The Lancet. Infectious diseases - 1 Apr 2009

Yuen Man-Fung, Fung James, Wong Danny Ka-Ho, Lai Ching-Lung

Abstract excerpt

Emergence of drug resistance in antiviral therapy for chronic hepatitis B negates treatment benefits. There is a lower chance for emergence of resistance for drugs with rapid and potent viral suppression and a high genetic barrier for resistant mutations. Measurement of viral load at 24 weeks' treatment to aid decision making is mandatory for patients receiving drugs that are associated with a higher resistance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B virus

Share to Hepatitis B Virus Studies

Share to Hepatitis C virus research

Share to Mutation

Share to Viral Load

Source

Identifiers

PMID: 19324298
DOI: 10.1016/S1473-3099(09)70056-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevention and management of drug resistance for antihepatitis B treatment.PMID 19324298Read ↗

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade.Semantic proximity Read ↗

Management of antiviral drug resistance in chronic hepatitis B.Semantic proximity Read ↗

Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance.Semantic proximity Read ↗

Management and prevention of drug resistance in chronic hepatitis B.Semantic proximity Read ↗

Antiviral‐resistant hepatitis B virus: can we prevent this monster from growing?Semantic proximity Read ↗

Treatment for hepatitis B in patients with drug resistanceSemantic proximity Read ↗

Chronic hepatitis B: preventing, detecting, and managing viral resistance.Semantic proximity Read ↗

Antiviral drug resistance: clinical consequences and molecular aspects.Semantic proximity Read ↗

The role of resistance in HCV treatment.Semantic proximity Read ↗

Drug Targets and Molecular Mechanisms of Drug Resistance in Chronic Hepatitis BSemantic proximity Read ↗

[Mechanisms of drug resistance in hepatitis viruses B and C].Semantic proximity Read ↗

[Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.